Care Access - Arlington — Arlington, Virginia

Care Access - Arlington is a clinical research site located in Arlington, Virginia, United States 22206.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Care Access - Arlington has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: Lichen Simplex Chronicus, Alzheimer Disease, Dermatitis Atopic.

Sponsors: Sanofi, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Arlington

Browse all research sites in Virginia · View every site in Arlington

• Virginia Hospital Center
• Fairfax Northern VA Hem-Onc PC
• Center for Optimal Aging, Marymount University
• Georgetown University Hospital
• Marymount University
• Arlington, VA Site
• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Virginia Cancer Specialists, PC
• Washington Cntr Weight Mgmt
• Millennium Clinical Trials

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access - Arlington?

Care Access - Arlington has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access - Arlington conducted?

Care Access - Arlington has 6 clinical trials on record, with 4 currently active. Their work covers Lichen Simplex Chronicus, Alzheimer Disease, Dermatitis Atopic.

Is Care Access - Arlington accredited by Crixeo Clinical Trials?

Care Access - Arlington has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access - Arlington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.